These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)]. Panel de expertos de GESIDA y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714 [TBL] [Abstract][Full Text] [Related]
4. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy. Senise JF; Castelo A; MartÃnez M AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356 [TBL] [Abstract][Full Text] [Related]
5. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764 [TBL] [Abstract][Full Text] [Related]
6. Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients. Hill A; Sawyer W HIV Med; 2009 Oct; 10(9):527-35. PubMed ID: 19785663 [TBL] [Abstract][Full Text] [Related]
7. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections]. Pozio E Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694 [TBL] [Abstract][Full Text] [Related]
8. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Sibiude J; Warszawski J; Tubiana R; Dollfus C; Faye A; Rouzioux C; Teglas JP; Ekoukou D; Blanche S; Mandelbrot L Clin Infect Dis; 2012 May; 54(9):1348-60. PubMed ID: 22460969 [TBL] [Abstract][Full Text] [Related]
10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy. Van Vaerenbergh K Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503 [TBL] [Abstract][Full Text] [Related]
13. Antiretroviral drugs in the treatment of people living with human immunodeficiency virus: experience in a south Indian tertiary referral centre. Kumarasamy N; Solomon S; Peters E; Amalraj RE; Purnima M; Ravikumar B; Yepthomi T; Thyagarajan SP J Assoc Physicians India; 2000 Apr; 48(4):390-3. PubMed ID: 11273171 [TBL] [Abstract][Full Text] [Related]
14. NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens. Joly V; Descamps D; Yeni P AIDS Rev; 2002; 4(3):128-39. PubMed ID: 12416447 [TBL] [Abstract][Full Text] [Related]
15. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Young J; Weber R; Rickenbach M; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC Antivir Ther; 2005; 10(5):585-91. PubMed ID: 16152752 [TBL] [Abstract][Full Text] [Related]
16. [Revised guideline "Antiretroviral Treatment"]. Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129 [TBL] [Abstract][Full Text] [Related]
18. High rebound of plasma and cellular HIV load after discontinuation of triple combination therapy. Jubault V; Burgard M; Le Corfec E; Costagliola D; Rouzioux C; Viard JP AIDS; 1998 Dec; 12(17):2358-9. PubMed ID: 9863885 [No Abstract] [Full Text] [Related]
20. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]